Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients.

O'Rorke MA, Murray LJ, Brand JS, Bhoo-Pathy N.

Cancer Treat Rev. 2016 Jun;47:12-21. doi: 10.1016/j.ctrv.2016.05.001. Epub 2016 May 11. Review.

PMID:
27214603
2.

Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: A historical cohort study.

Bhoo-Pathy N, Verkooijen HM, Wong FY, Pignol JP, Kwong A, Tan EY, Aishah Taib N, Nei WL, Ho GF, Tan B, Chan P, Lee SC, Hartman M, Yip CH, Dent R.

Int J Cancer. 2015 Nov 15;137(10):2504-12. doi: 10.1002/ijc.29617. Epub 2015 Jul 14.

3.

Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomy.

Chen X, Yu X, Chen J, Yang Z, Shao Z, Zhang Z, Guo X, Feng Y.

Oncologist. 2013;18(2):141-7. doi: 10.1634/theoncologist.2012-0233. Epub 2013 Jan 18.

4.

Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.

Kim S, Park HS, Kim JY, Ryu J, Park S, Kim SI.

Yonsei Med J. 2016 Sep;57(5):1192-8. doi: 10.3349/ymj.2016.57.5.1192.

5.

Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.

Kindts I, Buelens P, Laenen A, Van Limbergen E, Janssen H, Wildiers H, Weltens C.

Breast. 2017 Apr;32:18-25. doi: 10.1016/j.breast.2016.12.007. Epub 2016 Dec 22.

PMID:
28012411
6.

Breast-conserving therapy for triple-negative breast cancer.

Gangi A, Chung A, Mirocha J, Liou DZ, Leong T, Giuliano AE.

JAMA Surg. 2014 Mar;149(3):252-8. doi: 10.1001/jamasurg.2013.3037.

PMID:
24382582
7.

Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis.

Wang J, Xie X, Wang X, Tang J, Pan Q, Zhang Y, Di M.

Surg Oncol. 2013 Dec;22(4):247-55. doi: 10.1016/j.suronc.2013.10.001. Epub 2013 Oct 12. Review.

PMID:
24144808
8.

Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer.

Zumsteg ZS, Morrow M, Arnold B, Zheng J, Zhang Z, Robson M, Traina T, McCormick B, Powell S, Ho AY.

Ann Surg Oncol. 2013 Oct;20(11):3469-76. doi: 10.1245/s10434-013-3011-9. Epub 2013 May 19. Review.

9.

Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.

Perez CA, Zumsteg ZS, Gupta G, Morrow M, Arnold B, Patil SM, Traina TA, Robson ME, Wen YH, McCormick B, Powell SN, Ho AY.

Breast Cancer Res Treat. 2013 Jun;139(2):497-506. doi: 10.1007/s10549-013-2550-x. Epub 2013 May 5.

PMID:
23645006
10.

Adjuvant radiotherapy for stage I endometrial cancer.

Kong A, Johnson N, Kitchener HC, Lawrie TA.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD003916. doi: 10.1002/14651858.CD003916.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;(4):CD003916.

PMID:
22419290
11.

An overview of triple-negative breast cancer.

Kumar P, Aggarwal R.

Arch Gynecol Obstet. 2016 Feb;293(2):247-69. doi: 10.1007/s00404-015-3859-y. Epub 2015 Sep 4. Review.

PMID:
26341644
12.

Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.

Pan K, Guan XX, Li YQ, Zhao JJ, Li JJ, Qiu HJ, Weng DS, Wang QJ, Liu Q, Huang LX, He J, Chen SP, Ke ML, Zeng YX, Xia JC.

Clin Cancer Res. 2014 Jun 1;20(11):3003-11. doi: 10.1158/1078-0432.CCR-14-0082. Epub 2014 Mar 25.

13.

Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?

Parker CC, Ampil F, Burton G, Li BD, Chu QD.

Surgery. 2010 Aug;148(2):386-91. doi: 10.1016/j.surg.2010.05.018. Epub 2010 Jul 1.

PMID:
20580045
14.

Breast-conserving surgery with or without radiotherapy in older breast patients with early stage breast cancer: a systematic review and meta-analysis.

van de Water W, Bastiaannet E, Scholten AN, Kiderlen M, de Craen AJ, Westendorp RG, van de Velde CJ, Liefers GJ.

Ann Surg Oncol. 2014 Mar;21(3):786-94. doi: 10.1245/s10434-013-3374-y. Epub 2013 Nov 23. Review.

PMID:
24271158
15.

Radiation therapy in the locoregional treatment of triple-negative breast cancer.

Moran MS.

Lancet Oncol. 2015 Mar;16(3):e113-22. doi: 10.1016/S1470-2045(14)71104-0. Review.

PMID:
25752562
16.

Analysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors.

Colonna SV, Higgins AK, Alvarez J, Saville BR, Lawrence J, Abramson VG.

Clin Breast Cancer. 2016 Jun;16(3):223-31. doi: 10.1016/j.clbc.2015.10.001. Epub 2015 Nov 6.

PMID:
26683741
17.

[Safety of breast-conserving treatment for triple-negative breast cancer].

Wang L, Ouyang T, Wang T, Xie Y, Fan Z, Fan T, Li J.

Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):947-52. Chinese.

PMID:
26850668
18.

Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.

Levy A, Borget I, Bahri M, Arnedos M, Rivin E, Vielh P, Balleyguier C, Rimareix F, Bourgier C.

Breast J. 2014 Jul-Aug;20(4):381-7. doi: 10.1111/tbj.12277. Epub 2014 Jun 2.

PMID:
24890310
19.

The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy.

Lanning RM, Morrow M, Riaz N, McArthur HL, Dang C, Moo TA, El-Tamer M, Krause K, Siu C, Hsu M, Zhang Z, Pei X, McCormick B, Powell SN, Ho A.

Ann Surg Oncol. 2015 Aug;22(8):2517-25. doi: 10.1245/s10434-014-4321-2. Epub 2015 Jan 7.

PMID:
25564167
20.

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.

Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):622-30. doi: 10.1016/j.ijrobp.2015.07.006. Epub 2015 Jul 11.

PMID:
26461004

Supplemental Content

Support Center